- Home
- MVIS vs AUTL Comparison
MVIS vs AUTL Comparison
Compare MVIS & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MVIS | AUTL |
|---|---|---|
| Founded | 1993 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 403.3M | 368.6M |
| IPO Year | 1996 | 2018 |
Fundamental Metrics
Financial Performance| Metric | MVIS | AUTL |
|---|---|---|
| Price | $0.88 | $1.65 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $2.50 | ★ $8.33 |
| AVG Volume (30 Days) | ★ 4.9M | 3.8M |
| Earning Date | 11-11-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,635,000.00 | ★ $51,128,000.00 |
| Revenue This Year | N/A | $658.11 |
| Revenue Next Year | $859.00 | $91.34 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 406.67 |
| 52 Week Low | $0.80 | $1.11 |
| 52 Week High | $1.95 | $2.88 |
Technical Indicators
Market Signals| Indicator | MVIS | AUTL |
|---|---|---|
| Relative Strength Index (RSI) | 40.07 | 60.81 |
| Support Level | $0.91 | $1.46 |
| Resistance Level | $1.01 | $1.69 |
| Average True Range (ATR) | 0.06 | 0.10 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 35.72 | 89.33 |
Price Performance
Historical ComparisonAbout MVIS MicroVision Inc.
Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.